Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. 1990

E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235.

Fibrinolysis is regulated in part by the interaction between tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1, a serine protease inhibitor of the serpin family). It is known from our earlier work that deletion of a loop of amino acids (residues 296-302) from the serine protease domain of t-PA suppresses the interaction between the two proteins without altering the reactivity of t-PA towards its substrate, plasminogen. To define more precisely the role of individual residues within this loop, we have used site-directed mutagenesis to replace Lys-296, Arg-298, and Arg-299 with negatively charged glutamic residues. Replacement of all three positively charged amino acids generates a variant of t-PA that associates inefficiently with PAI-1 and is highly resistant to inhibition by the serpin. Two t-PAs with point mutations (Arg-298----Glu and Arg-299----Glu) are partially resistant to inhibition by PAI-1 and associate with the serpin at intermediate rates. Other point mutations (Lys-296----Glu, His-297----Glu, and Pro-301----Gly) do not detectably affect the interaction of t-PA with PAI-1. None of these substitutions has a significant effect on the rate of catalysis by t-PA or on the affinity of the enzyme for its substrate, plasminogen. On the basis of these results, we propose a model in which positively charged residues located in a surface loop near the active site of t-PA form ionic bonds with complementary negatively charged residues C-terminal to the reactive center of PAI-1.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012689 Sequence Homology, Nucleic Acid The sequential correspondence of nucleotides in one nucleic acid molecule with those of another nucleic acid molecule. Sequence homology is an indication of the genetic relatedness of different organisms and gene function. Base Sequence Homology,Homologous Sequences, Nucleic Acid,Homologs, Nucleic Acid Sequence,Homology, Base Sequence,Homology, Nucleic Acid Sequence,Nucleic Acid Sequence Homologs,Nucleic Acid Sequence Homology,Sequence Homology, Base,Base Sequence Homologies,Homologies, Base Sequence,Sequence Homologies, Base

Related Publications

E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
March 1991, The Journal of biological chemistry,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
February 1997, Trends in cardiovascular medicine,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
June 1991, The Journal of biological chemistry,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
November 1988, The Biochemical journal,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
June 1989, The Journal of biological chemistry,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
February 1988, The Journal of biological chemistry,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
September 2008, Seminars in thrombosis and hemostasis,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
January 2002, European journal of biochemistry,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
April 1995, The Journal of biological chemistry,
E L Madison, and E J Goldsmith, and R D Gerard, and M J Gething, and J F Sambrook, and R S Bassel-Duby
April 1989, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!